Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Market Analysis and Insights: Global Mono Hepatitis A Vaccine Market
The global Mono Hepatitis A Vaccine market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Mono Hepatitis A Vaccine Scope and Market Size
The global Mono Hepatitis A Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mono Hepatitis A Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine

Segment by Application
Government Institution
Private Sector
Other

The Mono Hepatitis A Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Mono Hepatitis A Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Kaketsuken
IMBCA
ChangSheng
Convac